Company intelligence / Profile preview

AJ Biologics

Petaling Jaya, Selangor, Malaysia

Ownership: Private
Employees: ~25
Development stage: Other

Overview

AJ Biologics operates a cGMP-compliant vaccine manufacturing facility in Malaysia that develops and produces pediatric and adult vaccines contributing to national immunization programs. The facility was the country's first dedicated vaccine plant, supporting both local and global disease eradication efforts. AJ Biologics focuses on vaccine co-development and collaborations to enhance accessibility and innovation; clinical outcomes data is not publicly detailed, but products are approved for immunization schedules in Malaysia and other markets.[2][3][5][6]

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologic
Industry: Biotech

Drug pipeline

2 assets

AJ Biologics ETEC vaccine

Preclinical

1 more asset in the full pipeline.

Request access →

Partnerships

ValnevaIMAXIOSK Chemicals

Beyond the preview

Go deeper on AJ Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AJ Biologics.

Explore the full profile